Wayne D. Tilley

Active 1989–2024

Also published as
Wayne D Tilley
111
Papers
17,931
Citations
86
h-index
111
i10-index

Citations

Citations per year for Wayne D. Tilley1989: 3 citations1990: 21 citations1991: 47 citations1992: 31 citations1993: 35 citations1994: 24 citations1995: 42 citations1996: 55 citations1997: 43 citations1998: 54 citations1999: 58 citations2000: 55 citations2001: 113 citations2002: 96 citations2003: 92 citations2004: 124 citations2005: 100 citations2006: 93 citations2007: 91 citations2008: 109 citations2009: 97 citations2010: 106 citations2011: 123 citations2012: 109 citations2013: 120 citations2014: 162 citations2015: 147 citations2016: 174 citations2017: 160 citations2018: 165 citations2019: 530 citations2020: 601 citations2021: 635 citations2022: 526 citations2023: 401 citations2024: 615 citations2025: 284 citations2026: 6 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,383 citing papers, 29.5% of this breakdownChina: 818 citing papers, 10.1% of this breakdownUnited Kingdom: 603 citing papers, 7.4% of this breakdownAustralia: 452 citing papers, 5.6% of this breakdownCanada: 330 citing papers, 4.1% of this breakdownItaly: 283 citing papers, 3.5% of this breakdownGermany: 241 citing papers, 3% of this breakdownFrance: 235 citing papers, 2.9% of this breakdownSpain: 192 citing papers, 2.4% of this breakdownNetherlands: 191 citing papers, 2.4% of this breakdownSweden: 172 citing papers, 2.1% of this breakdownJapan: 157 citing papers, 1.9% of this breakdown
0%29.5%Other 25.1%

Fields

  • Medicine46.6%
  • Biochemistry, Genetics and Molecular Biology45.3%
  • Immunology and Microbiology2.1%
  • Neuroscience1.3%
  • Chemistry1%
  • Computer Science1%
  • Other2.7%

Topics

  • Prostate Cancer Treatment and Research9.7%
  • Estrogen and related hormone effects5.3%
  • Prostate Cancer Diagnosis and Treatment2.8%
  • Hormonal and reproductive studies2.5%
  • Cancer, Lipids, and Metabolism2.2%
  • Cancer-related Molecular Pathways2.1%
  • Other75.4%

Coauthors

All papers

Open in search
  1. Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Suzanne K. Chambers, Leire Moya, Judith A. Clements, Lisa G. Horvath, Wayne D. Tilley, Gail P. Risbridger, Henrik Grönberg, Markus Aly, Tobias Nordström, Paul D.P. Pharoah, Nora Pashayan, Johanna Schleutker, Teuvo L.J. Tammela, Csilla Sipeky, Anssi Auvinen, Demetrius Albanes, Stephanie J. Weinstein, Alicja Wolk, Niclas Håkansson, Catharine West, Alison M. Dunning, N.G. Burnet, Lorelei A. Mucci, Edward Giovannucci, Gerald L. Andriole, Olivier Cussenot, Géraldine Cancel‐Tassin, Stella Koutros, Laura E. Beane Freeman, Karina D. Sørensen, Torben F. Ørntoft, Michael Borre, Lovise Mæhle, Eli Marie Grindedal, David E. Neal, Jenny Donovan, Freddie C. Hamdy, Richard M. Martin, Ruth C. Travis, Timothy J. Key, Robert J. Hamilton, Neil E. Fleshner, Antonio Finelli, Sue A. Ingles, Mariana C. Stern, Barry S. Rosenstein, Sarah L. Kerns, Harry Ostrer, Yong‐Jie Lu, Hong-Wei Zhang, Ninghan Feng, Xueying Mao, Xin Guo, Guomin Wang, Zan Sun, Graham G. Giles, Melissa C. Southey, Robert J. MacInnis, Liesel M. FitzGerald, Adam S. Kibel, Bettina F. Drake, Ana Vega, Antonio Gómez‐Caamaño, Robert Szulkin, Martin Eklund, Manolis Kogevinas, Javier Llorca, Gemma Castaño‐Vinyals, Kathryn L. Penney, Meir J. Stampfer and 92 more - Nature Genetics 2018 cited by 1,010

  2. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Melissa C. Southey, Robert J. MacInnis, Cezary Cybulski, Dominika Wokołorczyk, Jan Lubiński, David E. Neal, Jenny L. Donovan, Freddie C. Hamdy, Richard M. Martin, Børge G. Nordestgaard, Sune F. Nielsen, Maren Weischer, Stig E. Bojesen, Martin Andreas Røder, Peter Iversen, Jyotsna Batra, Suzanne K. Chambers, Leire Moya, Lisa G. Horvath, Judith A. Clements, Wayne D. Tilley, Gail P. Risbridger, Henrik Grönberg, Markus Aly, Robert Szulkin, Martin Eklund, Tobias Nordström, Nora Pashayan, Alison M. Dunning, Maya Ghoussaini, Ruth C. Travis, Timothy J. Key, Elio Ríboli, Jong Y. Park, Thomas A. Sellers, Hui‐Yi Lin, Demetrius Albanes, Stephanie J. Weinstein, Lorelei A. Mucci, Edward L. Giovannucci, Sara Lindström, Peter Kraft, David J. Hunter, Kathryn L. Penney, Constance Turman, Catherine M. Tangen, Phyllis J. Goodman, Ian M. Thompson, Robert J. Hamilton, Neil E. Fleshner, Antonio Finelli, Marie‐Elise Parent, Janet L. Stanford, Elaine A. Ostrander, Milan S. Geybels, Stella Koutros, Laura E. Beane Freeman, Meir J. Stampfer, Alicja Wolk, Niclas Håkansson, Gerald L. Andriole, Robert N. Hoover, Mitchell J. Machiela, Karina D. Sørensen, Michael Borre, William J. Blot, Wei Zheng, Edward D. Yeboah, James E. Mensah, Yong‐Jie Lu and 131 more - Nature Genetics 2021 cited by 500

  3. Targeting CDK2 in cancer: challenges and opportunities for therapy

    Authors: , , , , , , - Drug Discovery Today 2019 cited by 335

  4. Cyclin-Dependent Kinase 2 Inhibitors in Cancer Therapy: An Update

    Authors: , , , - Journal of Medicinal Chemistry 2018 cited by 286

  5. The androgen receptor is a tumor suppressor in estrogen receptor–positive breast cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2021 cited by 254

  6. Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kaori Muto, Akiko Nagai, Wataru Obara, Ken Yamaji, Kazuhisa Takahashi, Satoshi Asai, Yasuo Takahashi, Takao Suzuki, Nobuaki Sinozaki, Hiroki Yamaguchi, Shiro Minami, Shigeo Murayama, Kozo Yoshimori, Satoshi Nagayama, Daisuke Obata, Masahiko Higashiyama, Akihide Masumoto, Yukihiro Koretsune, Yuji Uchio, Michiaki Kubo, Yoichiro Kamatani, Artitaya Lophatananon, Peggy Wan, Caroline Andrews, Adriana Lori, Parichoy Pal Choudhury, Johanna Schleutker, Teuvo L. J. Tammela, Csilla Sipeky, Anssi Auvinen, Graham G. Giles, Melissa C. Southey, Robert J. MacInnis, Cezary Cybulski, Dominika Wokołorczyk, Jan Lubiński, Christopher T. Rentsch, Kelly Cho, Benjamin H. McMahon, David E. Neal, Jenny L. Donovan, Freddie C. Hamdy, Richard M. Martin, Børge G. Nordestgaard, Sune F. Nielsen, Maren Weischer, Stig E. Bojesen, Martin Andreas Røder, Hein Vincent Stroomberg, Jyotsna Batra, Suzanne K. Chambers, Lisa G. Horvath, Judith A. Clements, Wayne D. Tilley, Gail P. Risbridger, Henrik Grönberg, Markus Aly, Robert Szulkin, Martin Eklund, Tobias Nordström, Nora Pashayan, Alison M. Dunning, Maya Ghoussaini, Ruth C. Travis, Timothy J. Key, Elio Ríboli, Jong Y. Park, Thomas A. Sellers, Hui‐Yi Lin, Demetrius Albanes and 214 more - Nature Genetics 2023 cited by 143

  7. An androgen receptor switch underlies lineage infidelity in treatment-resistant prostate cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Luke A. Selth, Amina Zoubeidi - Nature Cell Biology 2021 cited by 163

  8. Progesterone receptor modulates ERα action in breast cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Nature 2015 cited by 675

  9. Dual Roles of PARP-1 Promote Cancer Growth and Progression

    Authors: , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2012 cited by 446

  10. Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Research 2021 cited by 84

  11. ELOVL5 Is a Critical and Targetable Fatty Acid Elongase in Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Luke A. Selth, Johannes V. Swinnen, Lisa M. Butler - Cancer Research 2021 cited by 96

  12. Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed Therapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeremy Grummet, Laurence Harewood, John Kourambas, Nathan Lawrentschuk, Daniel Moon, Declan G. Murphy, Shomik Sengupta, Ross Snow, Heather Thorne, Catherine Mitchell, John Pedersen, David Clouston, Sam Norden, Andrew Ryan, Scott M. Dehm, Wayne D. Tilley, Richard B. Pearson, Ross D. Hannan, Mark Frydenberg, Luc Furic, Renea A. Taylor, Gail P. Risbridger - European Urology 2018 cited by 119

  13. High-Throughput Imaging Assay for Drug Screening of 3D Prostate Cancer Organoids

    Authors: , , , , , , , , , , , , , , - SLAS DISCOVERY 2021 cited by 68

  14. Androgen Receptor Inhibits Estrogen Receptor-α Activity and Is Prognostic in Breast Cancer

    Authors: , , , , , , , , , , , , , , , - Cancer Research 2009 cited by 398

  15. Library size confounds biology in spatial transcriptomics data

    Authors: , , , , , , , , , , , , , , , - Genome biology 2024 cited by 44

  16. Androgen receptor signaling in castration-resistant prostate cancer: a lesson in persistence

    Authors: , , , - Endocrine Related Cancer 2016 cited by 194

  17. A patient‐derived explant (PDE) model of hormone‐dependent cancer

    Authors: , , , , , , , , , , , , , , , , , , , - Molecular Oncology 2018 cited by 131

  18. miR‐200/375 control epithelial plasticity‐associated alternative splicing by repressing the RNA‐binding protein Quaking

    Authors: , , , , , , , , , , , , , , , , , , , , - The EMBO Journal 2018 cited by 107

  19. Novel Selective Agents for the Degradation of Androgen Receptor Variants to Treat Castration-Resistant Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , - Cancer Research 2017 cited by 87

  20. Activity and safety of enobosarm, a novel, oral, selective androgen receptor modulator, in androgen receptor-positive, oestrogen receptor-positive, and HER2-negative advanced breast cancer (Study G200802): a randomised, open-label, multicentre, multinational, parallel design, phase 2 trial

    Authors: , , , , , , , , , , , , , , - The Lancet Oncology 2024 cited by 46

  21. Regulators of genetic risk of breast cancer identified by integrative network analysis

    Authors: , , , , , , , , , - Nature Genetics 2015 cited by 206

  22. Prostate cancer in a transgenic mouse.

    Authors: , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1995 cited by 1,300

  23. Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1

    Authors: , , , , , , - The EMBO Journal 2011 cited by 302

  24. MDM2 inhibition in combination with endocrine therapy and CDK4/6 inhibition for the treatment of ER-positive breast cancer

    Authors: , , , , , , , , , , , , , , , - Breast Cancer Research 2020 cited by 66